FAS, Fas cell surface death receptor, 355

N. diseases: 754; N. variants: 47
Disease: Liver diseases ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0023895
Disease: Liver diseases
Liver diseases 		0.230 Therapeutic group RGD Naringin attenuates liver damage in streptozotocin-induced diabetic rats. 29852394 2018
CUI: C0023895
Disease: Liver diseases
Liver diseases 		0.230 Biomarker group BEFREE Hepatocyte death is a central event during liver disease progression, in which immune cells play key roles by activating members of the Tumor Necrosis Factor Receptor Superfamily (TNFRSF), including TNFR1 (TNFRSF1A), Fas (TNFRSF6) and TRAIL-R2 (TNFRSF10B). 28835677 2017
CUI: C0023895
Disease: Liver diseases
Liver diseases 		0.230 Biomarker group BEFREE In contrast to that, statistically significant higher percentage of CD4+, CD8+, and CD19+ bearing Fas receptor in all groups of patients with liver diseases in comparison with the control subjects were estimated. 26429926 2016
CUI: C0023895
Disease: Liver diseases
Liver diseases 		0.230 AlteredExpression group BEFREE Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases. 16510204 2006